GSK plc 4
4 · Wave Life Sciences Ltd. · Filed Jan 30, 2024
Insider Transaction Report
Form 4
GLAXOSMITHKLINE PLC
10% Owner
Transactions
- Purchase
Ordinary Shares
2023-12-07$5.00/sh+3,300,000$16,500,000→ 13,983,761 total(indirect: By Corporation)
Footnotes (1)
- [F1]The shares reported herein are held of record by Glaxo Group Limited, a wholly-owned subsidiary of GSK plc (the "Reporting Person").